Amplification of Positivity + Cognitive Behavioral Therapy for Alcoholism
(AMP-A Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two therapy approaches for individuals dealing with both depression or anxiety and alcohol use issues. One group will undergo Amplification of Positivity Therapy, which boosts positive thoughts and feelings. The other group will receive Cognitive Behavioral Therapy (CBT), a well-known method that helps individuals understand the link between their thoughts and alcohol use. The trial aims to determine which approach better improves mood and reduces alcohol use. It seeks participants who struggle with alcohol use and experience significant depression or anxiety symptoms.
As an unphased trial, this study offers a unique opportunity to contribute to understanding effective therapies for mental health and alcohol use challenges.
Will I have to stop taking my current medications?
The trial requires that you have not changed the dose or prescription of any medication that could affect brain functioning in the 6 weeks before enrolling. You can continue taking antidepressants like SSRIs if the dose has been stable for 6 weeks. If you use benzodiazepines less than once a week, you may be included but must refrain from using them 72 hours before assessments.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Cognitive Behavioral Therapy (CBT) is generally safe for treating alcohol use problems. It has been extensively tested, and many people tolerate it well. Studies indicate that CBT, whether conducted online or in person, helps people reduce their drinking without major side effects.
For Amplification of Positivity Therapy, less detailed information is available. Past patients have demonstrated that this therapy is feasible and might be beneficial. However, as it remains in early testing, there is not yet as much solid data on its safety.
Both treatments in this trial involve talking with a therapist, not taking medication, which usually results in fewer physical side effects. Consulting a professional about any concerns before starting is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about Amplification of Positivity Therapy because it takes a unique approach to treating alcoholism by focusing on boosting positive thoughts, emotions, and behaviors. Unlike traditional therapies that often concentrate on reducing negative behaviors, this method aims to enhance well-being and potentially alleviate anxiety and depression, which can contribute to alcohol misuse. Meanwhile, Cognitive Behavioral Therapy (CBT) remains a strong option, as it helps individuals understand and change the relationship between their thoughts, emotions, and alcohol use, providing a more structured way to address these issues. Together, these therapies offer fresh perspectives and hope for individuals seeking to overcome alcohol addiction.
What evidence suggests that this trial's treatments could be effective for alcohol use disorder?
This trial will compare Amplification of Positivity Therapy (AMP) with Cognitive Behavioral Therapy (CBT) for treating alcohol use disorder. Research shows that AMP might assist individuals with alcohol use disorder, depression, and anxiety. Early studies with small groups suggest it could increase positive feelings and thoughts, potentially leading to reduced alcohol use. However, more detailed information is needed to determine its effectiveness.
In contrast, CBT is a well-known treatment for alcohol use disorder. Studies demonstrate that CBT effectively helps individuals reduce drinking by teaching them to understand and change the thoughts and feelings related to their drinking. It is a widely recommended treatment with strong evidence supporting its effectiveness.12346Who Is on the Research Team?
Robin L Aupperle, PhD
Principal Investigator
Laureate Institute for Brain Research
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 18-65 with alcohol use disorder and depression or anxiety, scoring above certain thresholds on the PHQ-9 or OASIS. Excluded are those using drugs affecting brain function, engaged in other psychosocial treatments for substance use or mood/anxiety within recent weeks, with severe medical conditions, MRI contraindications (Phase 2), or requiring intensive alcohol disorder treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase 1: Pilot Study
Initial pilot study to obtain qualitative and quantitative input from participants and clinicians to inform modifications to the AMP-A manual.
Phase 2: Randomized Clinical Trial
Participants are randomized to complete either the modified AMP-A intervention or a cognitive behavioral therapy (CBT) intervention.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of outcomes such as positive affect, depression, and anxiety.
What Are the Treatments Tested in This Trial?
Interventions
- Amplification of Positivity Therapy
- Cognitive Behavioral Therapy
Trial Overview
The study tests Amplification of Positivity Therapy (AMP-A) against Cognitive Behavioral Therapy (CBT) for people with both alcohol use disorder and depression/anxiety. Phase 1 refines AMP-A based on participant/clinician feedback. Phase 2 randomly assigns participants to either AMP-A or CBT to compare effectiveness via surveys/interviews and fMRI scans.
How Is the Trial Designed?
AMP-A will involve 12, one-hour weekly therapy sessions completed one-on-one with a therapist. The sessions and between-session homework will focus on amplifying positive thoughts, emotions, and behaviors to address anxiety/depression and alcohol use.
The CBT intervention will involve 12, one-hour weekly therapy sessions completed one-on-one with a therapist. The sessions and between-session homework will focus on monitoring of the relationship between thoughts, emotions, and alcohol use.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laureate Institute for Brain Research, Inc.
Lead Sponsor
University of California, San Diego
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Published Research Related to This Trial
Citations
Amplification of Positivity Therapy for Co-occurring Alcohol ...
The current study examined the feasibility and potential benefit of a behavioral intervention focused on amplification of positivity (AMP) with eight adults.
NCT06030154 | Amplification of Positivity for Alcohol Use
The current study would test the feasibility and acceptability of a 12-session protocol focused on amplification of positivity with populations experiencing ...
Amplification of Positivity Therapy for Co-occurring Alcohol ...
The current study examined the feasibility and potential benefit of a behavioral intervention focused on amplification of positivity (AMP) with ...
4.
scholars.okstate.edu
scholars.okstate.edu/en/publications/amplification-of-positivity-therapy-for-co-occurring-alcohol-use-Amplification of Positivity Therapy for Co-occurring Alcohol ...
The current study examined the feasibility and potential benefit of a behavioral intervention focused on amplification of positivity (AMP) with eight adults ( ...
Amplification of Positivity for Alcohol Use Disorder Co ...
The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure.
Amplification of Positivity + Cognitive Behavioral Therapy ...
Cognitive Behavioral Therapy (CBT) is generally considered safe for treating substance use disorders, including alcohol use disorder. However, there is no ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.